Jean‐Pierre Bergerat

3.7k total citations
80 papers, 2.5k citations indexed

About

Jean‐Pierre Bergerat is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Jean‐Pierre Bergerat has authored 80 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 21 papers in Pulmonary and Respiratory Medicine and 20 papers in Molecular Biology. Recurrent topics in Jean‐Pierre Bergerat's work include Prostate Cancer Treatment and Research (9 papers), Cancer Treatment and Pharmacology (8 papers) and Cancer-related Molecular Pathways (7 papers). Jean‐Pierre Bergerat is often cited by papers focused on Prostate Cancer Treatment and Research (9 papers), Cancer Treatment and Pharmacology (8 papers) and Cancer-related Molecular Pathways (7 papers). Jean‐Pierre Bergerat collaborates with scholars based in France, United States and Belgium. Jean‐Pierre Bergerat's co-authors include Jocelyn Céraline, Shanti Natarajan‐Amé, Jean‐Emmanuel Kurtz, Raoul Herbrecht, Bruno Lioure, P. Dufour, Valérie Letscher‐Bru, Barthel Barlogie, Benjamin Drewinko and Brigitte Duclos and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Jean‐Pierre Bergerat

79 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jean‐Pierre Bergerat France 25 702 699 615 572 565 80 2.5k
Taku Nakagawa Japan 28 888 1.3× 632 0.9× 519 0.8× 574 1.0× 471 0.8× 126 2.4k
Yosuke Hirotsu Japan 29 1.3k 1.9× 557 0.8× 550 0.9× 399 0.7× 482 0.9× 120 2.9k
Jinsheng Yu United States 27 1.2k 1.7× 568 0.8× 191 0.3× 409 0.7× 709 1.3× 53 2.9k
F Zintl Germany 37 1.2k 1.7× 1.3k 1.9× 326 0.5× 345 0.6× 259 0.5× 161 4.1k
Kazuaki Inoue Japan 28 686 1.0× 504 0.7× 290 0.5× 1.1k 1.9× 242 0.4× 107 2.8k
Bin Sun China 31 1.1k 1.6× 707 1.0× 418 0.7× 297 0.5× 357 0.6× 94 3.0k
Robert L. Capizzi United States 37 1.3k 1.8× 1.2k 1.7× 630 1.0× 265 0.5× 212 0.4× 134 4.0k
Mee Soo Chang South Korea 26 515 0.7× 744 1.1× 306 0.5× 721 1.3× 102 0.2× 106 2.2k
José D. Debes United States 22 596 0.8× 218 0.3× 458 0.7× 479 0.8× 211 0.4× 89 1.7k
J C Drake United States 28 1.8k 2.5× 1.6k 2.4× 504 0.8× 527 0.9× 478 0.8× 51 4.3k

Countries citing papers authored by Jean‐Pierre Bergerat

Since Specialization
Citations

This map shows the geographic impact of Jean‐Pierre Bergerat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐Pierre Bergerat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐Pierre Bergerat more than expected).

Fields of papers citing papers by Jean‐Pierre Bergerat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean‐Pierre Bergerat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐Pierre Bergerat. The network helps show where Jean‐Pierre Bergerat may publish in the future.

Co-authorship network of co-authors of Jean‐Pierre Bergerat

This figure shows the co-authorship network connecting the top 25 collaborators of Jean‐Pierre Bergerat. A scholar is included among the top collaborators of Jean‐Pierre Bergerat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean‐Pierre Bergerat. Jean‐Pierre Bergerat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barthélémy, Philippe, et al.. (2014). Pertuzumab et tumeurs solides : perspectives. Bulletin du Cancer. 101(12). 1114–1121. 2 indexed citations
2.
Impériale, Alessio, et al.. (2013). Isolated cerebellar metastasis from prostate adenocarcinoma diagnosed by 18F-fluorocholine PET/CT: a rare but not impossible complication. European Journal of Nuclear Medicine and Molecular Imaging. 41(2). 397–398. 4 indexed citations
3.
Guyader, Charlotte, Jocelyn Céraline, Eléonore Gravier, et al.. (2012). Risk of Hormone Escape in a Human Prostate Cancer Model Depends on Therapy Modalities and Can Be Reduced by Tyrosine Kinase Inhibitors. PLoS ONE. 7(8). e42252–e42252. 15 indexed citations
4.
Watkin, Emmanuel, Laurent Alberti, Adeline Duc, et al.. (2012). Insulin-like growth factor type 1 receptor (IGF-1R) exclusive nuclear staining: A predictive biomarker for IGF-1R monoclonal antibody (Ab) therapy in sarcomas. European Journal of Cancer. 48(16). 3027–3035. 92 indexed citations
5.
Céraline, Jocelyn, Brigitte Duclos, Philippe Barthélémy, et al.. (2011). New Strategies for Medical Management of Castration-Resistant Prostate Cancer. Oncology. 80(1-2). 1–11. 28 indexed citations
6.
Monet, Michaël, V’yacheslav Lehen’kyi, Florian Gackière, et al.. (2010). Role of Cationic Channel TRPV2 in Promoting Prostate Cancer Migration and Progression to Androgen Resistance. Cancer Research. 70(3). 1225–1235. 181 indexed citations
7.
8.
Lapouge, Gaëlle, Éva Erdmann, Pascal Kessler, et al.. (2007). Unexpected paracrine action of prostate cancer cells harboring a new class of androgen receptor mutation—A new paradigm for cooperation among prostate tumor cells. International Journal of Cancer. 121(6). 1238–1244. 23 indexed citations
9.
Bergerat, Jean‐Pierre. (2007). Place actuelle des inhibiteurs de l'aromatase dans le traitement adjuvant des cancers du sein. La Presse Médicale. 36(2). 333–340. 1 indexed citations
10.
Benzina, Sami, Barbara Fischer, P. Dufour, et al.. (2006). Cell death induced in a human glioblastoma cell line by p(65)+Be neutrons combined with cisplatin. Life Sciences. 79(6). 513–518. 10 indexed citations
11.
Kurtz, J.E., P. Dufour, Jean‐Pierre Bergerat, & F. Exinger. (2005). Saccharomyces Cerevisiae as a Genetic Model in Anticancer Therapy. 3(1). 1–7. 4 indexed citations
12.
Fischer, Barbara, Sami Benzina, P. Dufour, et al.. (2005). Fast neutrons-induced apoptosis is Fas-independent in lymphoblastoid cells. Biochemical and Biophysical Research Communications. 334(2). 533–542. 5 indexed citations
13.
Bischoff, Pierre, et al.. (2003). Signal Transduction Pathways of Taxanes-Induced Apoptosis. PubMed. 3(4). 291–306. 113 indexed citations
14.
Céraline, Jocelyn, Éva Erdmann, Philippe Erbs, et al.. (2003). Constitutive activation of the androgen receptor by a point mutation in the hinge region: A new mechanism for androgen‐independent growth in prostate cancer. International Journal of Cancer. 108(1). 152–157. 71 indexed citations
15.
Cazenave, Jean‐Pierre, et al.. (2001). Caffeine and the G2/M block override: A concept resulting from a misleading cell kinetic delay, independent of functional p53. International Journal of Cancer. 94(3). 363–369. 21 indexed citations
16.
Limacher, Jean‐Marc, Dominique Levêque, Brigitte Duclos, et al.. (1997). Pharmacokinetics of high-dose doxorubicin administered as a 6-h intravenousinfusion in breast cancer patients. Bulletin du Cancer. 84(6). 2 indexed citations
17.
Guriec, Nathalie, B Gairard, A Wilk, et al.. (1996). CD44 exon 6 expression as a possible early prognostic factor in primary node negative breast carcinoma. Clinical & Experimental Metastasis. 14(5). 434–439. 18 indexed citations
18.
Vincent, Florence, Alice Eischen, Henri de la Salle, et al.. (1991). Synthesis of Complement Components C2 and C4 by Human Monocyte-Derived Macrophages during in vitro Differentiation in Serum-Free Culture Conditions. Pathobiology. 59(3). 136–139. 2 indexed citations
19.
Lang, Jean-Marie, et al.. (1984). High-dose intravenous IgG for chronic idiopathic thrombocytopenic purpura in adults. Annals of Hematology. 49(2). 95–99. 12 indexed citations
20.
Basset, Paul, Jean‐Pierre Bergerat, Jean-Marie Lang, F Oberling, & Benjamin Gillet. (1981). Hemolytic Anemia and Sulfhemoglobinemia Due to Phenacetin Abuse: A Case with Multivisceral Adverse Effects. Clinical toxicology. 18(4). 493–499. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Taku Nakagawa Breakdown of academic impact, for papers by Yosuke Hirotsu Breakdown of academic impact, for papers by Jinsheng Yu Breakdown of academic impact, for papers by F Zintl Breakdown of academic impact, for papers by Kazuaki Inoue Breakdown of academic impact, for papers by Bin Sun Breakdown of academic impact, for papers by Robert L. Capizzi Breakdown of academic impact, for papers by Mee Soo Chang Breakdown of academic impact, for papers by José D. Debes Breakdown of academic impact, for papers by J C Drake
Rankless by CCL
2026